Rossari Biotech Limited (ROSSARI) — Financial Flexibility Index

Latest as of September 2023: 0.05x

Rossari Biotech Limited (ROSSARI) has a Financial Flexibility Index of 0.05x as of September 2023. Free cash flow of Rs302.28 Million (operating CF Rs302.28 Million minus capex Rs0.00) represents 0% of total liabilities (Rs5.56 Billion). Also explore net asset growth rate of Rossari Biotech Limited to track the company's year-over-year net asset growth rate.

Financial Flexibility Index

0.05x
Free Cash Flow / Total Liabilities

Free Cash Flow

Rs302.28 Million
Operating CF − Capex

Total Liabilities

Rs5.56 Billion
INR

Capital Expenditures

Rs0.00
INR

Rossari Biotech Limited Financial Flexibility Index (2017–2025)

Historical Financial Flexibility Index trend for Rossari Biotech Limited across 9 annual periods. Check ROSSARI PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.

Annual Financial Flexibility Index for Rossari Biotech Limited (2017–2025)

Year-by-year free cash flow to debt coverage for Rossari Biotech Limited. For the full company profile including market capitalisation, see ROSSARI market cap overview.

Year Flexibility Index Free Cash Flow (INR) Operating CF Total Liabilities YoY Change
2025 0.42x Rs2.96 Billion Rs1.37 Billion Rs7.11 Billion ▲ +25.1%
2024 0.33x Rs1.75 Billion Rs432.55 Million Rs5.24 Billion ▼ -18.7%
2023 0.41x Rs1.85 Billion Rs1.52 Billion Rs4.52 Billion ▲ +173.6%
2022 0.15x Rs675.83 Million Rs293.58 Million Rs4.52 Billion ▼ -78.4%
2021 0.69x Rs1.06 Billion Rs477.67 Million Rs1.53 Billion ▼ -2.0%
2020 0.71x Rs1.31 Billion Rs548.28 Million Rs1.85 Billion ▼ -22.6%
2019 0.91x Rs1.15 Billion Rs711.77 Million Rs1.26 Billion ▲ +80.2%
2018 0.51x Rs394.94 Million Rs255.69 Million Rs778.70 Million ▲ +306.1%
2017 0.12x Rs86.07 Million Rs46.95 Million Rs689.09 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities